{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:32:36Z","timestamp":1740148356586,"version":"3.37.3"},"reference-count":13,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Crohn's and Colitis"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.crohns.2014.09.007","type":"journal-article","created":{"date-parts":[[2014,10,11]],"date-time":"2014-10-11T03:00:10Z","timestamp":1412996410000},"source":"Crossref","is-referenced-by-count":9,"title":["Outcome of elective withdrawal of anti-tumour necrosis factor-\u03b1 therapy in patients with Crohn's disease in established remission"],"prefix":"10.1093","author":[{"given":"A.J.","family":"Brooks","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Sebastian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.S.","family":"Cross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Warren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1174-5473","authenticated-orcid":false,"given":"H.","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Majeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.E.","family":"McAlindon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Preston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.J.","family":"Hamlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.J.","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"issue":"9317","key":"10.1016\/j.crohns.2014.09.007_bb0005","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","article-title":"Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial","volume":"359","author":"Hanauer","year":"2002","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.crohns.2014.09.007_bb0010","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.gastro.2005.11.030","article-title":"Human anti-tumor necrosis factor monocolonal antibody (adalimumab) in Crohn's disease: the CLASSIC I trial","volume":"130","author":"Hanauer","year":"2006","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.crohns.2014.09.007_bb0015","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1136\/gut.2006.106781","article-title":"Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial","volume":"56","author":"Sandborn","year":"2007","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.crohns.2014.09.007_bb0020","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2006.11.041","article-title":"Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial","volume":"132","author":"Colombel","year":"2007","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.crohns.2014.09.007_bb0025","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1053\/j.gastro.2003.11.014","article-title":"Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease","volume":"126","author":"Rutgeerts","year":"2004","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.crohns.2014.09.007_bb0030","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.crohns.2012.02.017","article-title":"Adalimumab improves patient-related outcomes and reduces indirect costs in patients with moderate to severe Crohn's disease: results from the CARE trial","volume":"7","author":"Louis","year":"2013","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.crohns.2014.09.007_bb0035","unstructured":"NICE technology appraisal guidance 187 Infliximab (review) and adalimumab for the treatment of Crohn's disease (including a review of technology appraisal guidance 40).www.nice.org.uk\/guidance\/TA187. National Institute for Heath and Care Excellence. Issued: May 2010."},{"issue":"1","key":"10.1016\/j.crohns.2014.09.007_bb0040","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1053\/j.gastro.2011.09.034","article-title":"Maintenance of remission among patients with Crohn's disease on antimetabolite therapy after infliximab therapy is stopped","volume":"142","author":"Louis","year":"2012","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.crohns.2014.09.007_bb0045","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/apt.12160","article-title":"Predictors of relapse in patients with Crohn's disease in remission after 1year of biological therapy","volume":"37","author":"Molnar","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.crohns.2014.09.007_bb0050","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1365-2036.2010.04446.x","article-title":"Maintenance of clinical benefit in Crohn's disease patients after discontinuation of infliximab: long-term follow-up of a single centre cohort","volume":"32","author":"Waugh","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.crohns.2014.09.007_bb0055","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/apt.12499","article-title":"Adalimumab maintains remission of Crohn's disease after up to 4years of treatment: data from CHARM and ADHERE","volume":"38","author":"Panaccione","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.crohns.2014.09.007_bb0060","doi-asserted-by":"crossref","first-page":"235","DOI":"10.7861\/clinmedicine.12-3-235","article-title":"A prospective study of infliximab withdrawal after 12months of treatment in patients with Crohn's disease: how will NICE guidance affect patient care","volume":"12","author":"Blackmore","year":"2012","journal-title":"Clin Med"},{"issue":"12","key":"10.1016\/j.crohns.2014.09.007_bb0065","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1002\/ibd.22917","article-title":"Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease","volume":"18","author":"D'Haens","year":"2012","journal-title":"Inflamm Bowel Dis"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994614002888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994614002888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T18:15:32Z","timestamp":1498155332000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-lookup\/doi\/10.1016\/j.crohns.2014.09.007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":13,"alternative-id":["S1873994614002888"],"URL":"https:\/\/doi.org\/10.1016\/j.crohns.2014.09.007","relation":{},"ISSN":["1873-9946"],"issn-type":[{"type":"print","value":"1873-9946"}],"subject":[],"published":{"date-parts":[[2014,10]]}}}